Zusammenfassung
Es besteht eine bidirektionale Beziehung zwischen HSV-2 und HIV-1 sowohl auf zellulärer Ebene als auch bezüglich Transmission und ggf. Progression der HIV-1-Infektion. Es gibt deutliche Hinweise auf einen positiven Effekt einer antiherpetischen Therapie auf die Reduktion der HIV-1-Plasma- und Mukosaviruslast und HIV-1-Transmissionsrate. Die serologische Testung auf HSV-2 bei Personen mit erhöhtem HIV-1-Risiko sowie die Aufklärung der bidirektionalen Interaktion von HSV-2 und HIV-1 und eine entsprechende antiherpetische Suppressionstherapie können sowohl die HIV-1-Transmissionsrate senken, als auch zu einem individuellen klinischen Benefit der HIV-1-Infektion führen.
Abstract
There is a bidirectional relationship between HSV-2 and HIV-1, both at the cellular level, as well as regarding transmission and even progression of HIV-1 infection. There is clear evidence that anti-herpetic therapy reduces the plasma and mucosal HIV-1 viral load, as well as transmission. Serologic testing for HSV-2 in patients with an increased HIV-1 risk, coupled with a better understanding of the interaction between the viruses and appropriate anti-herpetic suppression therapy could both reduce the HIV-1 transmission rate and help the individual with an HIV infection.
Literatur
Bahrt B, Rabenau HF, Weber B et al. (1992) Prävalenz Herpes-simplex-Virus-Typ 2-spezifischer Antikörper bei Personen mit unterschiedlichem Infektionsrisiko. Z Hautkr 67(1): 56–58
Buxbaum S, Geers M, Gross G et al. (2003) Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? J Med Microbiol Immunol 192(3): 177–181
Celum CL (2004) The interaction between herpes simplex virus and human immunodeficiency virus. Herpes (Suppl 1): 36A–45A
Chenot JF, Doerr HW, Rabenau HF (2001) Laboratory diagnosis of herpes genitalis. Lab Med 25(7/8): 223–225
Chenot JF, Rabenau HF, Doerr HW (1999) Virologie, Epidemiologie und Diagnostik des Herpes genitalis. Dtsch Med Wochenschr 124: 158–162
Corey (2007) Synergistic Copathogens – HIV-1 and HSV-2. N Engl J Med 356(8): 854–856
Corey L (2007) Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues. J Infect Dis 195(9): 1242–1244
Doerr HW, Rabenau HF (1996) Dermatotrope Herpesviren: Infektionsbiologie, Epidemiologie und Diagnostik. Chemother J 5 (Suppl 10): 1–11
Doerr HW, Rabenau HF (2001) Die Laboratoriumsdiagnose von Infektionen mit Herpes simplex Virus (HSV), Cytomegalievirus (CMV) und Chlamydia trachomatis: Beiträge zur Optimierung konventioneller und molekularbiologischer Methoden des Erregernachweises. Pabst Science Publishers, Lengerich
Drake AL, John-Stewart GC, Wald A et al. (2007) Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission. Obstet Gynecol 109(2 Pt 1): 403–409
Golden MP, Kim S, Hammer SM et al. (1992) Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 166: 494–499
Gray RH, Wawer MJ, Brookmeyer R et al. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357(9263): 1149–1153
Haas I, Mühlbauer G, Bozic M et al. (2004) Evaluation of a new assay for detection of herpes simplex virus type 1 and type 2 DNA by real-time PCR. J Lab Med 28(4): 361–367
Kessler HH, Mühlbauer G, Rinner B et al. (2000) Detection of herpes simplex virus DNA by real-time PCR. J Clin Microbiol 38(7): 2638–2642
Lafferty WE, Coombs RW, Benedetti J et al. (1987) Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 316(23): 1444–1449
Lafferty WE, Downey L, Celum C, Wald A (2000) Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 181(4): 1454–1457
Langenberg AG, Corey L, Ashley RL et al. (1999) A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 341(19): 1432–1438
Lingappa JR, Celum C (2007) Clinical and therapeutic issues for herpes simplex virus-2 and HIV Co-infection. Drugs 67(2): 155–174
Lowhagen GB, Tunback P, Andersson K et al. (2000) First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 76(3): 179–182
Mbopi-Keou FX, Gresenguet G, Mayaud P et al. (2000) Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 182(4): 1090–1096
Mindel A (1995) Recent advances in genital herpes. Ann Acad Med Singapore 24(4): 584–592
Nagot N, Ouedraogo A, Foulongne V et al. (2007) Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 356(8): 790–799
Nilsen A, Myrmel H (2000) Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 79(8): 693–696
Palu G, Benetti L, Calistri A (2001) Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes 8(2): 50–55
Preiser W, Doerr HW, Buxbaum S et al. (2004) Acute retinal necrosis six years after herpes simplex encephalitis: an elusive immune deficit suggested by insufficient test sensitivity. J Med Virol 73(2): 250–255
Preiser W, Rabenau HF, Doerr HW (2002) Viren – Viruserkrankungen – Synopsis der Klinik, Diagnostik und Therapie viraler Erkrankungen. Zett, Steinen, S 1–228
Rabenau HF, Berger A (2006) Indikationen für die molekulare Diagnostik – Viren. In: Thiemann, Cullen, Klein (Hrsg) Leitfaden für die molekulare Diagnostik. Grundlagen, Tipps und Tricks für die Praxis. Wissenschaftsverlag Wiley-VCH, Weinheim, S 145–174
Rabenau HF, Buxbaum S, Preiser W et al. (2002) Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. J Med Microbiol Immunol 190: 153–160
Rabenau HF, Eibner J, Weber B, Doerr HW (1992) Detection of Herpes simplex virus (HSV) type specific antibodies by a microtechnique Western blot assay. Lab Med 16: 327–331
Rabenau HF, Helmerich A, Weber B (1999) Verbesserte Labordiagnose der Herpes simplex Virus Infektion: Evaluierung eines modifizierten schnellen Shell-Vial-Assays zur Detektion und Typisierung von Herpes simplex Viren. Lab Med 23(11): 614–620
Rabenau HF, Runne U, Selb B, Doerr HW (1986) Die Labordiagnose von Herpes simplex: Nachweis von Virusantigen mit dem Enzyme-linked-immunosorbent-assay und dem direkten Immunfluoreszenztest. Lab Med 10: 324–326
Sakrauski A, Weber B, Kessler HH et al. (1994) Comparison of two hybridization assays for the rapid detection of PCR amplified HSV genome sequences from cerebrospinal fluid. J Virol Methods 50(1–3): 175–184
Schacker T (2001) The role of HSV in the transmission and progression of HIV. Herpes 8(2): 46–49
Schacker T, Zeh J, Hu HL et al. (1998) Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 178(6): 1616–1622
Singh R, Kumar A, Creery WD et al. (2003) Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Clin Exp Immunol 133(1): 97–107
Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis;186 (Suppl 1): S3–28
Vogel JU, Weber B, Doerr HW (1994) Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol 281(4): 502–512
Wald A, Link K (2002) Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 185(1): 45–52
Wutzler P, Doerr HW, Färber I et al. (2000) Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations – relation and relevance for the incidence of herpes genitalis. J Medical Virol 61: 201–207
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabenau, H., Doerr, H. Genitaler Herpes und HSV-Transmission bei HIV-Patienten. Hautarzt 59, 11–17 (2008). https://doi.org/10.1007/s00105-007-1443-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-007-1443-5